Promising new 'antigene' therapy

Uses light energy to silence gene activity

2010-10-22

(Press-News.org) New Rochelle, NY, October 21, 2010—Antigene therapy is a promising new treatment strategy that uses a DNA-based drug to pinpoint light energy to a target gene shutting down its activity. A review article published online ahead of print in Oligonucleotides, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com), details the possibilities and challenges for the clinical application of this novel photo-activated DNA modulating approach. The article is available free online at www.liebertpub.com/oli

Netanel Kolevzon and Eylon Yavin, from The Hebrew University of Jerusalem (Israel), describe the mechanism behind antigene therapy in the article "Site-Specific DNA Photocleavage and Photomodulation by Oligonucleotide Conjugates." They review the development of triplex-forming DNA-based drugs capable of up-regulating or inhibiting gene expression in a highly targeted and selective manner.

Unlike existing antisense therapies that target RNA, an antigene drug is a triplex-forming oligonucleotide that recognizes and attaches directly to a specific DNA sequence. By attaching a photoreactive agent to the antigene and delivering light energy to the attachment site, the light-sensitive drug complex becomes activated, triggering a cleavage or cross-linking reaction. This photo-induced, site-specific DNA damage effectively silences the gene target.

"Many obstacles lay ahead before this approach may reach the clinic," caution the authors. However, if antigene therapy proves successful at blocking gene activity, "many diseases that are currently incurable or otherwise treatable with limited success could be potentially relevant targets for such an approach," they conclude.

"This is a clever and potentially powerful approach to targeted regulation of gene expression," says John Rossi, PhD, Co-Editor-in-Chief of Oligonucleotides and Professor in the Department of Molecular Biology, Beckman Research Institute of the City of Hope (Duarte, CA).

INFORMATION:

Oligonucleotides, edited by John Rossi, PhD, and C.A. Stein, MD, PhD, from the Department of Oncology at Albert Einstein-Montefiore Cancer Center, is an authoritative, peer-reviewed journal published 6 times a year in print and online that focuses on synthetic oligonucleotides, including RNA, DNA, and ribozymes, and their effects on gene expression at the RNA and DNA levels both in vitro and in vivo. It represents a forum for basic research and applied therapeutics for the purpose of developing new concepts and experimental approaches to understanding and modulating gene activity. Oligonucleotides is the Official Journal of the Oligonucleotide Therapeutics Society (http://www.myots.org). Tables of content and a free sample issue may be viewed online at www.liebertpub.com/oli

Mary Ann Liebert, Inc. (www.liebertpub.com), is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy, ASSAY and Drug Development Technologies, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at www.liebertpub.com

Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
www.liebertpub.com

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Coccolithophore blooms in the southwest Atlantic

2010-10-22

A study led by Dr Stuart Painter of the National Oceanography Centre helps explain the formation of huge phytoplankton blooms off the southeast coast of South America during the austral summer (December-January). The region supports the highly productive Patagonian Shelf marine ecosystem, which includes a globally important fishery. Coccolithophores are key members of the marine phytoplankton community. They are abundant in the sunlit upper layer of the world's oceans, often forming vast blooms that can be seen from space. "Coccolithophores are a complex group of plankton ...

Future offenses cause more intense feelings than past actions, Chicago Booth study finds

2010-10-22

People feel worse about a transgression that will take place in the future than an identical one that occurred in the past, according to new research from the University of Chicago Booth School of Business. Thinking about future events tends to stir up more emotions than events in the past, said Eugene Caruso, an assistant professor of behavioral science at Chicago Booth who conducted the research which appeared recently in the Journal of Experimental Psychology: General. Whether an event has happened or will happen, can affect people's perceptions of fairness and ...

Teaching kids to work through trauma

2010-10-22

A child who grows up in the midst of political conflict, such as war or terrorism, can exhibit severe emotional scars. But certain qualities, which psychologists call "resilience factors," can help overcome this adversity. Prof. Michelle Slone of Tel Aviv University's Department of Psychology has now developed a program to help children develop these resilience factors and avoid the psychological disabilities that may arise from stress. Her method ― and her inspiring results ― were recently described in the Journal of Child Psychology and Psychiatry and International ...

Chicago racial disparities in breast cancer mortality significantly higher than national average

2010-10-22

Disparities in breast cancer mortality continue to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards. The Sinai Urban Health Institute has been tracking mortality data since it first brought attention to the problem in 2006 ...

Egg meets sperm: The female side of the story

2010-10-22

Researchers at the Swedish medical university Karolinska Institutet have been able to describe the 3D structure of a complete egg receptor that binds sperm at the beginning of fertilization. The results, published in the journal Cell, will lead to better understanding of infertility and may enable entirely new types of contraceptives. For centuries, the imagination of people has been grasped by the encounter of gametes – egg and sperm-, whose union gives rise to a new individual. At the beginning of conception, sperm binds to proteins in the extracellular coat of the ...

ER patients prefer ordering physicians discuss risks/benefits of CT with them before ordering exam

2010-10-22

The majority of emergency department patients consider having their condition correctly diagnosed with computed tomography (CT) more important than any associated radiation risk. However, two-thirds of patients prefer their ordering physician discuss the risks and benefits of CT with them before ordering the imaging test, according to a study in the November issue of the American Journal of Roentgenology (www.ajronline.org). "Because patients drive their care to some degree, it is important for physicians to understand patients' knowledge and attitudes about radiation ...

BUSM study shows patient navigations improve mammography rates in minority women

2010-10-22

(Boston) – A new research study conducted by Boston University School of Medicine (BUSM) shows that patient navigation services significantly improve biennial mammography screening rates among inner city women. The results, published online in the Journal of General Internal Medicine, indicate the importance of patient navigation in reducing health disparities in vulnerable patient populations. Breast cancer is the second leading cause of cancer death in women, with 40,170 deaths in the United States in 2009. Lower mammography screening rates among minority and low ...

Offshore wind a 'mixed bag': University of Maryland study

2010-10-22

COLLEGE PARK, Md. - Offshore wind power offers a feasible way for Maryland to help meet its renewable energy goals, but presents some economic and political hurdles, concludes a new study by the University of Maryland Center for Integrative Environmental Research (CIER). The study, "Maryland Offshore Wind Development," is the most in-depth feasibility assessment to date of developing and operating wind farms in Maryland's Atlantic coastal waters, the researchers say. Among the study's key findings, offshore wind development will have to address two serious hurdles to ...

Barrow scientists uncover clues on inflammation in central nervous system

2010-10-22

(PHOENIX, AZ) -- Scientists at Barrow Neurological Institute have recently made discoveries about a type of cell that may limit inflammation in the central nervous system (CNS) – a finding that could have important implications in the treatment of brain disorders such as multiple sclerosis. The research, led by Barrow's Fu-Dong Shi, MD, PhD, was published in the August 2010 issue of The Journal of Experimental Medicine, and simultaneously highlighted in Nature. Dr. Shi directs the Neuroimmunology Laboratory and Flow Cytometry Core Facility at Barrow. One of his research ...

Malaria-transmitting mosquito evolving, NIH grantees find

2010-10-22

WHAT: Researchers funded by the National Institutes of Health have found that the major malaria-transmitting mosquito species, Anopheles gambiae, is evolving into two separate species with different traits, a development that could both complicate malaria control efforts and potentially require new disease prevention methods. Their findings were published in back-to-back articles in the October 22 issue of the journal Science. A. gambiae is the most common vector of human malaria in sub-Saharan Africa, where rates of the disease are highest. The researchers compared the ...

Promising new 'antigene' therapy

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: